180 related articles for article (PubMed ID: 27812217)
21. A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.
Müller J; Wastling J; Sanderson S; Müller N; Hemphill A
Antimicrob Agents Chemother; 2007 Jun; 51(6):1979-86. PubMed ID: 17438059
[TBL] [Abstract][Full Text] [Related]
22. An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.
Voak AA; Gobalakrishnapillai V; Seifert K; Balczo E; Hu L; Hall BS; Wilkinson SR
J Biol Chem; 2013 Oct; 288(40):28466-76. PubMed ID: 23946481
[TBL] [Abstract][Full Text] [Related]
23. A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase.
El-Hossary EM; Förstner KU; François P; Baud D; Streker K; Schrenzel J; Ohlsen K; Holzgrabe U
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133557
[TBL] [Abstract][Full Text] [Related]
24. Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness).
Tweats D; Bourdin Trunz B; Torreele E
Mutagenesis; 2012 Sep; 27(5):523-32. PubMed ID: 22539226
[TBL] [Abstract][Full Text] [Related]
25. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
26. Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.
Patterson S; Wyllie S
Trends Parasitol; 2014 Jun; 30(6):289-98. PubMed ID: 24776300
[TBL] [Abstract][Full Text] [Related]
27. Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538.
Yamada M; Espinosa-Aguirre JJ; Watanabe M; Matsui K; Sofuni T; Nohmi T
Mutat Res; 1997 Apr; 375(1):9-17. PubMed ID: 9129675
[TBL] [Abstract][Full Text] [Related]
28. Development of a Multiplexed Assay for Detection of
Abeijon C; Alves F; Monnerat S; Wasunna M; Mbui J; Viana AG; Bueno LL; Siqueira WF; Carvalho SG; Agrawal N; Fujiwara R; Sundar S; Campos-Neto A
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787142
[TBL] [Abstract][Full Text] [Related]
29. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural alterations induced by nifurtimox and another nitro derivative on epimastigotes of Trypanosoma cruzi.
Muelas-Serrano S; Pérez-Serrano J; Gómez-Barrio A; Arán VJ; Rodríguez-Caabeiro F
Parasitol Res; 2002 Feb; 88(2):97-101. PubMed ID: 11936510
[TBL] [Abstract][Full Text] [Related]
31. Identification of a RAC/AKT-like gene in Leishmania parasites as a putative therapeutic target in leishmaniasis.
Varela-M RE; Ochoa R; Muskus CE; Muro A; Mollinedo F
Parasit Vectors; 2017 Oct; 10(1):458. PubMed ID: 29017516
[TBL] [Abstract][Full Text] [Related]
32. Evaluating 5-Nitrothiazoles as Trypanocidal Agents.
O'Shea IP; Shahed M; Aguilera-Venegas B; Wilkinson SR
Antimicrob Agents Chemother; 2016 Feb; 60(2):1137-40. PubMed ID: 26596950
[TBL] [Abstract][Full Text] [Related]
33. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole.
Hof H
Antimicrob Agents Chemother; 1989 Mar; 33(3):404-5. PubMed ID: 2729935
[TBL] [Abstract][Full Text] [Related]
35. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.
Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S
Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564
[TBL] [Abstract][Full Text] [Related]
36. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
Zhang WW; Ghosh AK; Mohamath R; Whittle J; Picone A; Lypaczewski P; Ndao M; Howard RF; Das P; Reed SG; Matlashewski G
BMC Infect Dis; 2018 Oct; 18(1):500. PubMed ID: 30285653
[TBL] [Abstract][Full Text] [Related]
37. Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.
Mondelaers A; Sanchez-Cañete MP; Hendrickx S; Eberhardt E; Garcia-Hernandez R; Lachaud L; Cotton J; Sanders M; Cuypers B; Imamura H; Dujardin JC; Delputte P; Cos P; Caljon G; Gamarro F; Castanys S; Maes L
PLoS One; 2016; 11(4):e0154101. PubMed ID: 27123924
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.
Abass E; Kang C; Martinkovic F; Semião-Santos SJ; Sundar S; Walden P; Piarroux R; El Harith A; Lohoff M; Steinhoff U
PLoS One; 2015; 10(3):e0116408. PubMed ID: 25734336
[TBL] [Abstract][Full Text] [Related]
39. Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824.
Kutty R; Bennett GN
Arch Microbiol; 2005 Nov; 184(3):158-67. PubMed ID: 16187099
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.
Yang Y; Voak A; Wilkinson SR; Hu L
Bioorg Med Chem Lett; 2012 Nov; 22(21):6583-6. PubMed ID: 23031595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
